Leadership Team 2011-2012

President

Zhihong Chen, Ph. D.

Sr. Research Investigator, Eisai Research Institute, Andover, MA

 

Vice Presidents

Zhiyong Yang, Ph. D.

Principal Scientist, Pfizer BioTherapeutics Research, Cambridge, MA

Qinglin Che, Ph. D.

Research Scientist, Syntha Pharmaceuticals, Inc., Lexington, MA

Sue Ma, M. D.

Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA

 

Executive Committee Members

Ellen Fan

Scientist II, Arsenal Medical Inc. Watertown, MA

Kevin Fang, Ph. D.

Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA

Fred Hu, Ph. D.

Principal Research Scientist, Pfizer Inc., Cambridge, MA

Jia Huang, Ph. D.

Scientist, Allergan Inc., Medford, MA

Shengfang Jin, Ph. D.

Director/Cell Biology, Agios Pharmaceuticals, Inc., Cambridge, MA

Susan Qu, Ph.D. MBA

Principal Project Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA

Jinbo Lee, Ph. D.

President, Sage Partner International Inc., Cambridge, MA

Fushuang Liu

Vice President, Wuxi Howfond Biopharma, Co. Ltd., Jiangshu, China

Ji Shi

Senior Market Research Analyst, Boston Biomedical Consultants, Waltham, MA

Shallwei Sun

General Manager, Callisyn Biomedical, Inc, North Andover, MA

Ze Tian, Ph. D.

Instructor, Dana Farber Cancer Institute/Harvard Medical School, Boston, MA

Yongzhong Wang, Ph. D.

Deputy General Manager, Kanghong Biotechnology Co. Ltd., Chengdu, China

Yueming Wang, MBA

Deputy General Manager, Tide Pharmaceutical Co. Ltd., Beijing, China

Zhigang Wang, Ph. D.

Sr. Principal Scientist, Avila Therapeutics, Inc. Bedford, MA

Roger Xie, Ph. D.

Co-founder, EVP, Head of Global Development, China PharmaHub Corp., Cambridge, MA

Yongwen (Tony) Yuan

Director, Sciligence, Weston, MA

Philip Zhang, Ph. D.

Co-Founder and Co-Managing Principal, Milstein Zhang & Wu LLC, Newton, MA

Wei Zhang, Ph. D.

Staff Scientist, Siemens Healthcare Diagnostics, Norwood, MA

Weiyi (Wendy) Zhang, Ph. D.

President, Boston Lincoln International, Lincoln, MA

Zhendong Zhu, Ph. D.

Principal Scientist, Pfizer Research Technology Center, Cambridge, MA

Board of Directors

Chaoyang Dai, Ph. D.

Vice President of Operations, Acebright, Inc. Bedford, MA

Jun Han, Ph. D.

Founding President

CEO, SOTA International LLC, Boston, MA

Shiwen Lin, Ph. D.

Associate Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA

Lixin Shen, Ph. D.

President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China

Zhao-Kui Wan, Ph. D.; Immediate Past-President

Sr. Principal Scientist, Pfizer Inc., Cambridge, MA

Yihan Wang, Ph. D.; Chairman of the Board

Associate Director/Chemistry, ARIAD Pharmaceuticals, Inc., Cambridge, MA

Erxi Wu, Ph. D.

Assistant Prof., North Dakota State University, Fargo, ND

Junjun Wu, Ph. D.; Past President

Principal Research Scientist, Pfizer Inc., Cambridge, MA

CABA Legal Council

Fred Gilman

Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA

CABA Advisors

Youssef Bennani, Ph. D.

Vice President/Discovery Chemistry, Vertex Pharmaceuticals Inc., Cambridge, MA

Tim Clackson, Ph. D.

President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Yuan-Hua Ding, ph.D.

Senior Director & Head of External R&D Innovation - Asia, Pfizer

Pierre Dodion, M. D., MBA

Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA

Chen Li, Ph. D.

Chief Executive Officer, Hua Medicine, Inc., Shanghai, China

Shi Li, Ph. D.

CEO, Zerun Biotechnology, Shanghai, CHINA

Yuanli Liu, Ph. D.

Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health

Dawei Ma , Ph. D.

Professor, Shanghai Institute of Organic Chemistry, Shanghai, China

Tarek Mansour, Ph. D.

EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada

Tse Ping

Chairman, Sino Biopharmaceutical Ltd., Beijing, China

John Piwinski, Ph. D.

Principal, JJPiwinski Pharma Consulting, LLC, New York, NY

Steve Projan, Ph. D.

Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD

Tomi Sawyer, Ph. D.

Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA

Liming Shao, Ph. D.

Senior Director/Medicinal Chemistry, Sepracor Inc., Marlborough, MA

Suvit Thaisrivongs, Ph. D.

Vice President, Pfizer, Inc., Cambridge. MA

Roger Tung, Ph. D.

CEO and President, Concert Pharmaceuticals, Lexington, MA

Yibin Xiang, Ph. D.

Senior Director/Medicinal Chemistry, Genzyme Corporation, Cambridge, MA

Gangfeng Xu, Ph. D.

Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories

Steve Yang, Ph. D.

Head of R&D, Asia & Emerging Markets, AstraZeneca

Howard Yuwen, Ph. D.

Sr. Director, Regulatory Affair, Shire Human Genetics Therapies, Cambridge, MA